BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 30219970)

  • 21. Evidence for a heritable contribution to neuroendocrine tumors of the small intestine.
    Neklason DW; VanDerslice J; Curtin K; Cannon-Albright LA
    Endocr Relat Cancer; 2016 Feb; 23(2):93-100. PubMed ID: 26604321
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Independent somatic evolution underlies clustered neuroendocrine tumors in the human small intestine.
    Elias E; Ardalan A; Lindberg M; Reinsbach SE; Muth A; Nilsson O; Arvidsson Y; Larsson E
    Nat Commun; 2021 Nov; 12(1):6367. PubMed ID: 34737276
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TCEB3C a putative tumor suppressor gene of small intestinal neuroendocrine tumors.
    Edfeldt K; Ahmad T; Åkerström G; Janson ET; Hellman P; Stålberg P; Björklund P; Westin G
    Endocr Relat Cancer; 2014 Apr; 21(2):275-84. PubMed ID: 24351681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Implications of Pathogenic Germline Variants in Small Intestine Neuroendocrine Tumors (SI-NETs).
    Perez K; Kulke MH; Chittenden A; Ukaegbu C; Astone K; Alexander H; Brais L; Zhang J; Garcia J; Esplin ED; Yang S; Da Silva A; Nowak JA; Yurgelun MB; Garber J; Syngal S; Chan J
    JCO Precis Oncol; 2021 Nov; 5():808-816. PubMed ID: 34994613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CDKN1B mutation and copy number variation are associated with tumor aggressiveness in luminal breast cancer.
    Viotto D; Russo F; Anania I; Segatto I; Rampioni Vinciguerra GL; Dall'Acqua A; Bomben R; Perin T; Cusan M; Schiappacassi M; Gerratana L; D'Andrea S; Citron F; Vit F; Musco L; Mattevi MC; Mungo G; Nicoloso MS; Sonego M; Massarut S; Sorio R; Barzan L; Franchin G; Giorda G; Lucia E; Sulfaro S; Giacomarra V; Polesel J; Toffolutti F; Canzonieri V; Puglisi F; Gattei V; Vecchione A; Belletti B; Baldassarre G
    J Pathol; 2021 Feb; 253(2):234-245. PubMed ID: 33140857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The neuroendocrine phenotype, genomic profile and therapeutic sensitivity of GEPNET cell lines.
    Hofving T; Arvidsson Y; Almobarak B; Inge L; Pfragner R; Persson M; Stenman G; Kristiansson E; Johanson V; Nilsson O
    Endocr Relat Cancer; 2018 Mar; 25(3):367-380. PubMed ID: 29444910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A
    Dumanski JP; Rasi C; Björklund P; Davies H; Ali AS; Grönberg M; Welin S; Sorbye H; Grønbæk H; Cunningham JL; Forsberg LA; Lind L; Ingelsson E; Stålberg P; Hellman P; Tiensuu Janson E
    Endocr Relat Cancer; 2017 Aug; 24(8):427-443. PubMed ID: 28634180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Familial small-intestine carcinoids: Chromosomal alterations and germline inositol polyphosphate multikinase sequencing.
    de Mestier L; Pasmant E; Fleury C; Brixi H; Sohier P; Féron T; Diebold MD; Clauser E; Cadiot G;
    Dig Liver Dis; 2017 Jan; 49(1):98-102. PubMed ID: 27825921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiomic sequencing of paired primary and metastatic small bowel carcinoids.
    Postel MD; Darabi S; Howe JR; Liang WS; Craig DW; Demeure MJ
    F1000Res; 2023; 12():417. PubMed ID: 37954063
    [No Abstract]   [Full Text] [Related]  

  • 30. A plausible role for actin gamma smooth muscle 2 (ACTG2) in small intestinal neuroendocrine tumorigenesis.
    Edfeldt K; Hellman P; Westin G; Stalberg P
    BMC Endocr Disord; 2016 Apr; 16():19. PubMed ID: 27107594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A nomogram to assess small-intestinal neuroendocrine tumor ('carcinoid') survival.
    Modlin IM; Gustafsson BI; Pavel M; Svejda B; Lawrence B; Kidd M
    Neuroendocrinology; 2010; 92(3):143-57. PubMed ID: 20733279
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patterns of chromosome 18 loss of heterozygosity in multifocal ileal neuroendocrine tumors.
    Zhang Z; Mäkinen N; Kasai Y; Kim GE; Diosdado B; Nakakura E; Meyerson M
    Genes Chromosomes Cancer; 2020 Sep; 59(9):535-539. PubMed ID: 32291827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mucinous phenotype and CD10 expression of primary adenocarcinoma of the small intestine.
    Kumagai R; Kohashi K; Takahashi S; Yamamoto H; Hirahashi M; Taguchi K; Nishiyama K; Oda Y
    World J Gastroenterol; 2015 Mar; 21(9):2700-10. PubMed ID: 25759539
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Whole genome sequencing reveals the independent clonal origin of multifocal ileal neuroendocrine tumors.
    Mäkinen N; Zhou M; Zhang Z; Kasai Y; Perez E; Kim GE; Thirlwell C; Nakakura E; Meyerson M
    Genome Med; 2022 Aug; 14(1):82. PubMed ID: 35922826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetics of adenocarcinomas of the small intestine: frequent deletions at chromosome 18q and mutations of the SMAD4 gene.
    Bläker H; von Herbay A; Penzel R; Gross S; Otto HF
    Oncogene; 2002 Jan; 21(1):158-64. PubMed ID: 11791187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The ETS oncogene family transcription factor FEV identifies serotonin-producing cells in normal and neoplastic small intestine.
    Wang YC; Zuraek MB; Kosaka Y; Ota Y; German MS; Deneris ES; Bergsland EK; Donner DB; Warren RS; Nakakura EK
    Endocr Relat Cancer; 2010 Mar; 17(1):283-91. PubMed ID: 20048018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liver metastases of small intestine neuroendocrine tumors: Ki-67 heterogeneity and World Health Organization grade discordance with primary tumors.
    Shi C; Gonzalez RS; Zhao Z; Koyama T; Cornish TC; Hande KR; Walker R; Sandler M; Berlin J; Liu EH
    Am J Clin Pathol; 2015 Mar; 143(3):398-404. PubMed ID: 25696798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic significance of lymph node metastases in small intestinal neuroendocrine tumors.
    Kim MK; Warner RR; Ward SC; Harpaz N; Roayaie S; Schwartz ME; Itzkowitz S; Wisnivesky J
    Neuroendocrinology; 2015; 101(1):58-65. PubMed ID: 25572143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The genetic alterations of rectal neuroendocrine tumor and indications for therapy and prognosis: a systematic review.
    Li K; Liu Y; Han J; Gui J; Zhang X
    Endocr J; 2023 Feb; 70(2):197-205. PubMed ID: 36403965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential methylation of G-protein coupled receptor signaling genes in gastrointestinal neuroendocrine tumors.
    Byun S; Affolter KE; Snow AK; Curtin K; Cannon AR; Cannon-Albright LA; Thota R; Neklason DW
    Sci Rep; 2021 Jun; 11(1):12303. PubMed ID: 34112938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.